71P - Investigating molecular biomarkers in SCLC
|Date||28 March 2014|
|Session||Lunch and poster display session|
|Topics|| Small-Cell Lung Cancer
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
F. Abdelraouf1, D. Gonzalez de Castro2, A. Wotherspoon3, M. Maurya2, D. Mair2, J. Bhosle4, S. Popat4, M. O'Brien5
Small cell lung cancer (SCLC) is an aggressive cancer that relapses quickly after conventional treatment. Molecular biomarkers have been investigated in non-small cell lung cancer (NSCLC) and targeted treatments in advanced disease are established. Currently there are no established targeted therapies in SCLC and the aim of this study was to examine for the presence of known molecular targets in patients with SCLC.